Literature DB >> 23891092

Influence of internal mammary node irradiation on long-term outcome and contralateral breast cancer incidence in node-negative breast cancer patients.

Adel Courdi1, Emmanuel Chamorey, Jean-Marc Ferrero, Jean-Michel Hannoun-Lévi.   

Abstract

BACKGROUND AND
PURPOSE: There is no general consensus concerning irradiation (RT) of internal mammary nodes (IMN) in axillary node-negative breast cancer. Based on a large series of patients treated in a single institute and followed up for a long period of time, we looked at the influence of IMN RT on late outcome of these patients as well as the development of contralateral breast cancer (CBC). PATIENTS AND METHODS: The study was based on 1630 node-negative breast cancer patients treated in our institution between 1975 and 2008 with primary conservative surgery and axillary dissection or sentinel node examination. All patients received post-operative breast RT. IMN RT was more frequent in inner or central tumours. Kaplan-Meier (K-M) overall survival (OS), cancer-specific survival (CSS), and disease-free survival (DFS) according to IMN RT were calculated for all patients and for patients with inner/central tumours. The K-M rate of contralateral breast cancer (CBC) was also analysed and correlated with IMN RT.
RESULTS: Prognostic variables such as tumour size, histological grade, and hormone receptors were not significantly different in the groups having received IMN RT or not. Considering all patients, OS was strictly comparable in the 2 groups: 10-year values were 85% (IMN RT) and 86% (no IMN RT), respective values at 20 years were 66.6% and 61.0% (p=0.95). However, in patients presenting with inner/central tumours, OS was significantly improved in the IMN RT group with respective values of 92.5% and 87.2% at 10 years, and 80.2% and 63.3% at 20 years: Hazard ratio (HR)=0.56 (0.37-0.85); p=0.0052. Again, CSS was improved in patients with inner/central tumours having received IMN RT, with 20-year rates of 89.5% versus 79.1% in patients not receiving IMN RT (p=0.047). No difference in DFS was noticed. The actuarial rate of CBC development was comparable between patients having received IMN RT and other patients. However, considering only patients alive 10 years after primary breast surgery, the K-M rate of CBC at 20 years was 5.3% in patients without IMN RT and 7.2% in patients with such RT; HR=2.47 (1.23-4.95); p=0.008.
CONCLUSIONS: IMN RT in node-negative tumours was associated with increase in OS and CSS in patients with inner or centrally located lesions. An increase in CBC development was also noticed in long-survivors of IMN RT patients; however, these findings have to be interpreted with caution because of the difference in follow-up between the 2 groups. Further studies are warranted to investigate the potential role of IMN irradiation in the development of CBC.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Contralateral breast cancer; Inner tumours; Internal mammary nodes irradiation; Outcome; Survival

Mesh:

Year:  2013        PMID: 23891092     DOI: 10.1016/j.radonc.2013.06.028

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  12 in total

1.  DEGRO practical guidelines: radiotherapy of breast cancer III--radiotherapy of the lymphatic pathways.

Authors:  M-L Sautter-Bihl; F Sedlmayer; W Budach; J Dunst; P Feyer; R Fietkau; C Fussl; W Haase; W Harms; M D Piroth; R Souchon; F Wenz; R Sauer
Journal:  Strahlenther Onkol       Date:  2014-03-05       Impact factor: 3.621

2.  [The pendulum swings back - lymphatic irradiation of breast cancer is in favor again].

Authors:  Hartmut T Klages
Journal:  Strahlenther Onkol       Date:  2014-05       Impact factor: 3.621

3.  [Internal mammary node irradiation in early node-positive breast cancer: Improved survival].

Authors:  M-L Sautter-Bihl; F Sedlmayer
Journal:  Strahlenther Onkol       Date:  2016-04       Impact factor: 3.621

Review 4.  The lymph node microenvironment and its role in the progression of metastatic cancer.

Authors:  Ethel R Pereira; Dennis Jones; Keehoon Jung; Timothy P Padera
Journal:  Semin Cell Dev Biol       Date:  2015-01-22       Impact factor: 7.727

5.  Why do we need irradiation of internal mammary lymph nodes in patients with breast cancer: Analysis of lymph flow and radiotherapy studies.

Authors:  Novikov Sergey Nikolaevich; Kanaev Sergey Vasilevich
Journal:  Rep Pract Oncol Radiother       Date:  2016-10-22

6.  Comparison of two treatment strategies for irradiation of regional lymph nodes in patients with breast cancer: Lymph flow guided portals versus standard radiation fields.

Authors:  Sergey Nikolaevich Novikov; Sergey Vasilevich Kanaev; Vladimir Fedorovich Semiglazov; Ludmila Alekseevna Jukova; Pavel Ivanovich Krzhivitckiy
Journal:  Rep Pract Oncol Radiother       Date:  2014-07-19

7.  Prognostic significance of the primary tumor site and immune indexes in patients with estrogen receptor-positive, human epidermal growth factor receptor-2-negative breast cancer.

Authors:  Xinming Song; Jianli Ma; Han Zhang; Qingyuan Zhang
Journal:  Gland Surg       Date:  2020-10

Review 8.  Evolution of radiotherapy techniques in breast conservation treatment.

Authors:  John Boyages; Lesley Baker
Journal:  Gland Surg       Date:  2018-12

9.  Adjuvant radiotherapy of regional lymph nodes in breast cancer - a meta-analysis of randomized trials.

Authors:  Wilfried Budach; Kai Kammers; Edwin Boelke; Christiane Matuschek
Journal:  Radiat Oncol       Date:  2013-11-14       Impact factor: 3.481

10.  Practical consensus recommendations regarding role of postmastectomy radiation therapy.

Authors:  D Singh; G Saini; R Koul; V Gupta; D Abrol; S De; P Kulshrestha; S N Hukku; S J Lakshmi; Purvish M Parikh; S Aggarwal
Journal:  South Asian J Cancer       Date:  2018 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.